Approvals/TGA/Evoke CAP12 Trial Percutaneous Lead Kit - Implantable lumbar neuromuscular electrical stimulation system lead

Approved

STANDARD

Evoke CAP12 Trial Percutaneous Lead Kit - Implantable lumbar neuromuscular electrical stimulation system lead

Saluda Medical Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6485701da2e33a20
Product Name: Evoke CAP12 Trial Percutaneous Lead Kit - Implantable lumbar neuromuscular electrical stimulation system lead
Artg Id: 508088
Artg Name: Saluda Medical Pty Ltd - Evoke CAP12 Trial Percutaneous Lead Kit - Implantable lumbar neuromuscular electrical stimulation system lead
Sponsor: Saluda Medical Pty Ltd
Artg Date: 2025-08-05
Registration Type: Device
Therapeutic Good Type: Medical device
Licence Status: A
Licence Category: INC

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

6485701da2e33a20

Type

Standard